Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Rubius Therapeutics (RUBY) News Today

Rubius Therapeutics logo

RUBY Latest News

How to Get the Exclusive Rubius Fortnite Drop
Rubius Therapeutics Inc RUBY
RUBY - Rubius Therapeutics, Inc.
North American Morning Briefing: Alphabet, -2-
Former Rubius CEO jumps to another Flagship spinout
Rubius Therapeutics, Inc. (RUBY)
Rubius Therapeutics Inc
Flagship-backed Vesalius lays off 43%
Rubius Therapeutics scraps platform, lays off 160
Rubius Therapeutics Announces Strategic Update
Rubius Therapeutics to Provide Strategic Update
Rubius Therapeutics: Q2 Earnings Insights
Rubius Therapeutics Inc - Stock News
What 6 Analyst Ratings Have To Say About Rubius Therapeutics
Get Rubius Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for RUBY and its competitors with MarketBeat's FREE daily newsletter.

RUBY Media Mentions By Week

RUBY Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

RUBY
News Sentiment

0.00

0.90

Average
Medical
News Sentiment

RUBY News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

RUBY Articles
This Week

0

0

RUBY Articles
Average Week

Get Rubius Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for RUBY and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:RUBY) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners